Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A team of KWTRP scientists carried out a major genomic epidemiology of SARS-CoV-2 infections in Kenya during the early phase of the epidemic (March – July 2020). Researchers provide evidence for at least 35-40 unique introductions of the virus in the coast region – specifically the epidemic that was largely observed in Mombasa County.

Group photo of KWTRP sequencing team

Published in Nature, this work by George Githinji and colleagues shows that Europe was a major source of introductions into Kenya. They also saw evidence of introductions through ports of entry with neighbouring countries which however did not establish local transmissions. Control efforts by the Ministry of Health at the time were aimed at limiting local transmission and reducing the number of global introductions.

Government efforts and Ministry of Health guidelines were important control measures and partly worked by reducing introduction of specific lineages from taking hold and potentially slowed down the number of infections. Nonetheless a few asymptomatic cases were sufficient to seed the epidemic. This underlines the severe challenge to the strategy that aimed at preventing the introduction of virus as any cases that escaped the net had potential to establish community spread.

The full story is available on the KWTRP website

Read the publication Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya on the Nature website

Similar stories

Cross-species vaccination by Professor George Warimwe

Royal Society 2021 Africa Prize lecture from Professor George Warimwe. More than 70% of emerging infectious diseases (including viruses) are zoonotic, meaning they are acquired from animals, with some causing serious illness and death in humans as well as the animal host. But, what if we could immunise both humans and animals with the same vaccine?

New! A learning framework about antimicrobial resistance for children and young people

A downloadable resource for educators, health & research professionals to help develop young peoples’ understanding of AMR and positive actions they can take to mitigate it.

Peter Macharia wins RSTMH Emerging Leader Award

Peter Macharia is a spatial epidemiologist and a postdoc interested in disease mapping, healthcare access and mapping population vulnerabilities at KEMRI Wellcome. He received the RSTMH 2021 Emerging Leader Award, which recognises significant contributions in leadership, mentoring and capacity building in those who are early in their careers.

Congratulations new Associate Professors

Following the meeting of the Medical Sciences Divisional Committee to consider applications for the conferral of the title of Associate Professor, we are pleased to announce that Rashan Haniffa, Dorcas Kamuya, Isabella Oyier, Le Van Tan and Timothy Walker have been awarded the title Associate Professor

Reducing children’s exposure to malaria in their early years substantially cuts the risk of hospitalisation.

For the first time in more than two decades, a team from the KEMRI-Wellcome Trust Research Programme and University of Oxford have quantified the risk of children suffering severe outcomes from malaria - which can have a devastating impact on tens of thousands of children who are admitted to hospital with severe malaria every year.

Royal Society Africa Prize 2021 awarded to George Warimwe

The Royal Society Africa Prize 2021 is awarded to Professor George Warimwe for his work on zoonoses vaccine development, capacity building in Africa, and his innovative research proposal. This Prize recognises research scientists based in Africa who are making an innovative contribution to the sciences.